Dr. Omar Rossi is Head of the Serology and Immunology Unit at the GSK Vaccines Institute for Global Health. He completed his Ph.D. studies in Industrial and molecular Biotechnology at the Novartis Institute for BioMedical Research (Ph.D. program of the University of Naples Federico II) in 2014. His doctoral research focused on the characterization and detoxification of Toll-like Receptor-activating components in GMMA purified from Shigella, Salmonella, and Neisseria species. His research interests include the immunological characterization of responses induced by candidate vaccines at both preclinical and clinical levels.